Interleukin-22 mitigates acute respiratory distress syndrome (ARDS).
<h4>Background</h4>The goal of this study was to determine if IL-22:Fc would Acute Respiratory Distress Syndrome (ARDS).<h4>Summary background data</h4>No therapies exist for ARDS and treatment is purely supportive. Interleukin-22 (IL-22) plays an integral component in recove...
Guardado en:
Autores principales: | Sharven Taghavi, Olan Jackson-Weaver, Sarah Abdullah, Alanna Wanek, Robert Drury, Jacob Packer, Aaron Cotton-Betteridge, Juan Duchesne, Derek Pociask, Jay Kolls |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8cfca3eb512e481c988245ba33a718e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
por: Seyed MohammadReza Hashemian, et al.
Publicado: (2021) -
¿Arde Bolivia?
Publicado: (2006) -
¿Arde París?
por: Collins, Larry, et al.
Publicado: (1997) -
AVDS should not dethrone ARDS
por: Yazine Mahjoub, et al.
Publicado: (2021) -
Interleukin-22 and keratinocytes; pathogenic implications in skin inflammation
por: Masutaka Furue, et al.
Publicado: (2021)